HEMTIVTI Trademark

Trademark Overview


On Tuesday, August 3, 2021, a trademark application was filed for HEMTIVTI with the United States Patent and Trademark Office. The USPTO has given the HEMTIVTI trademark a serial number of 90863206. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, October 21, 2024. This trademark is owned by Pfizer Inc.. The HEMTIVTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of hemophilia
hemtivti

General Information


Serial Number90863206
Word MarkHEMTIVTI
Filing DateTuesday, August 3, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, October 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use; pharmaceutical preparations for the treatment of hemophilia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-2193

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, August 6, 2021NEW APPLICATION ENTERED
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 26, 2022ASSIGNED TO EXAMINER
Wednesday, April 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 17, 2022NEW NOA TO ISSUE
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 28, 2023SOU EXTENSION 1 FILED
Friday, April 28, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 4, 2023SOU EXTENSION 2 FILED
Wednesday, October 4, 2023SOU EXTENSION 2 GRANTED
Friday, October 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 25, 2024SOU EXTENSION 3 FILED
Thursday, April 25, 2024SOU EXTENSION 3 GRANTED
Friday, April 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 21, 2024SOU EXTENSION 4 FILED
Monday, October 21, 2024SOU EXTENSION 4 GRANTED